Himanshu Mody To Step Down As CFO Of Suzlon Energy
Himanshu Mody is set to step down as Chief Financial Officer (CFO) of Suzlon Energy Limited, effective August 31, 2025.
Krithika Vijay Karthik Appointed As Company Secretary Of Anjani Portland Cement
Krithika Vijay Karthik has been appointed as Company Secretary and Compliance Officer of Anjani Portland Cement Limited with effect from August 12, 2025.
Thomas Dohmke Resigns As GitHub CEO, Integration With Microsoft CoreAI Announced
Thomas Dohmke, Chief Executive Officer (CEO) of GitHub, will step down after nearly four years in the role, marking his exit from both GitHub and Microsoft.
Dinesh Khanna Joins Singtel Board As Non-Executive Director
Singtel has appointed Dinesh Khanna to its Board as a Non-Executive Non-Independent Director.
Rahul Pinjarkar Steps Down As CHRO Of Tata Chemicals
Rahul Pinjarkar, Chief Human Resource Officer (CHRO) and Senior Management Personnel (SMP) of Tata Chemicals Limited, has resigned and has been relieved from the services with effect from August 9, 2025.
Satish Satyarthi To Step Down As Chief Innovation Officer Of Eureka Forbes & Pragya Kaul To Step Down As Company Secretary
Satish Satyarthi, Chief Innovation and R&D Officer (Senior Managerial Personnel) of Eureka Forbes Limited, has tendered his resignation due to personal and family reasons with effect from September 28, 2025.
Satish K. Agarwal Reappointed As CMD Of Kamdhenu; Sunil K. Agarwal & Sachin Agarwal As Whole-Time Directors
Satish Kumar Agarwal has been reappointed as Chairman and Managing Director (CMD) of Kamdhenu Limited with effect from April 1, 2026, subject to the approval of shareholders.
Gaurav Swarup Retires As Independent Director Of Graphite India
Gaurav Swarup has retired as an Independent Director of Graphite India Limited, effective August 10, 2025.
Bharat Kanaiyalal Sheth Replaces Hemant Nerurkar As Independent Director Of Adani Enterprises
Bharat Kanaiyalal Sheth has been appointed as Non-Executive Independent Director (Additional Director) of Adani Enterprises Limited, effective August 9, 2025, subject to approval of the shareholders.
Dr. Vinay Prasad Resumes Leadership Role At FDA’s Biologics Division
Dr. Vinay Prasad is resuming leadership of the Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) at the agency’s request, according to the U.S. Department of Health and Human Services.
